Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy

OBJECTIVE: To compare the efficacy and safety of recombinant human prourokinase (rhPro-UK) and alteplase for thrombolytic therapy in acute ST-segment elevation myocardial infarction (STEMI) and to analyze the related factors affecting efficacy. METHODS: From January 2017 to December 2019, 100 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yizhou, Yang, Yulin, Li, Ying, Peng, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440075/
https://www.ncbi.nlm.nih.gov/pubmed/34531919
http://dx.doi.org/10.1155/2021/6702965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440075/
https://www.ncbi.nlm.nih.gov/pubmed/34531919
http://dx.doi.org/10.1155/2021/6702965

Ejemplares similares